You are here

Sanofi

AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again

Fierce Pharma

Fri, 04/26/24 - 11:18 am

atopic dermatitis

Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1

BioSpace

Thu, 04/25/24 - 05:56 pm

Sanofi profit slips on generic competition and currency effects

Reuters

Thu, 04/25/24 - 05:47 pm

Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint

Clinical Trials Arena

Tue, 04/23/24 - 10:51 am

Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg

Fierce Pharma

Mon, 04/22/24 - 05:59 pm

Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group

Fierce Pharma

Thu, 04/18/24 - 10:30 pm

IGM and Sanofi collaboration will pivot to immunology and inflammation

Pharmaceutical Technology

Wed, 04/17/24 - 10:09 pm

IGM Biosciences

Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff

BioSpace

Thu, 04/11/24 - 10:22 pm

Sanofi begins 'full pipeline reprioritization' with layoffs in tow, R&D chief tells staff

Fierce Biotech

Fri, 04/5/24 - 11:26 am

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

Reuters

Wed, 04/3/24 - 10:25 pm

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024

BioSpace

Wed, 03/27/24 - 11:06 am

After decades of waiting, late-stage therapies may penetrate the COPD market this year

Clinical Trials Arena

Sun, 03/24/24 - 10:31 pm

drug development

Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial

Fierce Biotech

Mon, 03/11/24 - 11:52 am

clinical trials

prurigo nodularis

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter

Stat

Thu, 03/7/24 - 05:35 pm

monoclonal antibodies

With Sanofi left as the lone supplier of tetanus shots in the US, CDC warns of shortage

Fierce Pharma

Fri, 03/1/24 - 11:50 am

Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment

Clinical Trials Arena

Thu, 02/29/24 - 11:11 am

eosinophilic esophagitis

Sanofi CEO Hudson takes another small dip in pay to €10.57M

Fierce Pharma

Mon, 02/26/24 - 05:15 pm

executive compensation

Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial

Clinical Trials Arena

Mon, 02/26/24 - 10:35 am

chronic spontaneous urticaria

clinical trials

Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD

BioSpace

Fri, 02/23/24 - 10:43 am

priority review

Sanofi's planned consumer health spinoff picks up interest from multiple firms

Fierce Pharma

Wed, 02/21/24 - 10:35 pm

consumer healthcare

Pages